Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

AZD3199

"Low dose~Dry powder for inhalation, o.d., 1+12 days"

DRUG

Placebo

DRUG

AZD3199

"intermediate dose~Dry powder for inhalation, o.d., 1+12 days"

DRUG

AZD3199

"high dose~Dry powder for inhalation, o.d., 1+12 days"

Trial Locations (1)

Unknown

Research Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY